OBJECTIVE: We studied the cost of health care for women with breast cancer treated at the Mexican Social Security Institute (IMSS, per its abbreviation in Spanish). MATERIAL AND METHODS: Using the Medical and Operative Information Systems of the IMSS, we constructed a cohort of patients diagnosed in 2002 and followed these patients to the end of 2006, identifying the use of resources and imputing the IMSS-specific cost structure. RESULTS: Only 14% of women were diagnosed in stage 1 and 48% were diagnosed in stages III-IV. The average cost of their medical care per patient-year was $MX110,459. Costs for stage 1 were $MX74,522 compared to $102,042 for stage II, and were $MX154,018 for stage III and $MX199,274 for stage IV. CONCLUSIONS: Breast cancer accounts for a significant part of the IMSS health budget. Later stage at diagnosis is associated with higher economic costs per patient-year of treatment and lower probability of five-year survival.
OBJECTIVE: We studied the cost of health care for women with breast cancer treated at the Mexican Social Security Institute (IMSS, per its abbreviation in Spanish). MATERIAL AND METHODS: Using the Medical and Operative Information Systems of the IMSS, we constructed a cohort of patients diagnosed in 2002 and followed these patients to the end of 2006, identifying the use of resources and imputing the IMSS-specific cost structure. RESULTS: Only 14% of women were diagnosed in stage 1 and 48% were diagnosed in stages III-IV. The average cost of their medical care per patient-year was $MX110,459. Costs for stage 1 were $MX74,522 compared to $102,042 for stage II, and were $MX154,018 for stage III and $MX199,274 for stage IV. CONCLUSIONS:Breast cancer accounts for a significant part of the IMSS health budget. Later stage at diagnosis is associated with higher economic costs per patient-year of treatment and lower probability of five-year survival.
Authors: Andrea B Cruz-Castillo; María A Hernández-Valero; Shelly R Hovick; Martha Elva Campuzano-González; Miguel Angel Karam-Calderón; L Patricia Bustamante-Montes Journal: J Cancer Educ Date: 2015-09 Impact factor: 2.037
Authors: Nancy L Keating; Elena M Kouri; Héctor Arreola Ornelas; Oscar Méndez; Laura Magaña Valladares; Felicia Marie Knaul Journal: Oncologist Date: 2014-09-17
Authors: Matthew P Banegas; Yelena Bird; John Moraros; Sasha King; Surasri Prapsiri; Beti Thompson Journal: J Womens Health (Larchmt) Date: 2011-10-04 Impact factor: 2.681
Authors: Gabriela Torres-Mejía; Robert A Smith; María de la Luz Carranza-Flores; Andy Bogart; Louis Martínez-Matsushita; Diana L Miglioretti; Karla Kerlikowske; Carolina Ortega-Olvera; Ernesto Montemayor-Varela; Angélica Angeles-Llerenas; Sergio Bautista-Arredondo; Gilberto Sánchez-González; Olga G Martínez-Montañez; Santos R Uscanga-Sánchez; Eduardo Lazcano-Ponce; Mauricio Hernández-Ávila Journal: BMC Cancer Date: 2015-05-16 Impact factor: 4.430
Authors: Laurens M Niëns; Sten G Zelle; Cristina Gutiérrez-Delgado; Gustavo Rivera Peña; Blanca Rosa Hidalgo Balarezo; Erick Rodriguez Steller; Frans F H Rutten Journal: PLoS One Date: 2014-04-25 Impact factor: 3.240